• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Shineco (SISI) Stock Is Down 50%

    7/12/24 10:38:50 AM ET
    $SISI
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $SISI alert in real time by email

    Shineco Inc (NASDAQ:SISI) shares are trading lower by 53.6% to $0.98 during Friday’s session after the company announced pricing of a $2 million underwritten public offering.

    The company earlier said its public offering of 1,869,160 shares of common stock will be at $1.07 per share, totaling approximately $2 million before expenses. The company also granted underwriters a 45-day option to purchase an additional 280,374 shares to cover over-allotments.

    The offering is set to close on July 15, pending customary closing conditions. EF Hutton LLC is the sole book-running manager for the offering.

    Read Also: June Producer Inflation Exceeds Forecasts, Restrains Investor Euphoria Following Consumer Price Relief

    Should I Sell My SISI Stock?

    When deciding to hold on to or sell a stock, investors should consider their time horizon, unrealized gains and total return.

    Shares of Shineco have decreased by 65.71% in the past year. An investor who bought shares of Shineco at the beginning of the year would take a loss of $0.24 per share if they sold it today. The stock has fallen 74.12% over the past month, meaning an investor who bought shares on Jun. 1 would see a capital loss of $1.19.

    Investors may also consider market dynamics. The Relative Strength Index can be used to indicate whether a stock is overbought or oversold. Shineco stock currently has an RSI of 40.41, indicating neutral conditions.

    For access to advanced charting and analysis tools and stock data, check out Benzinga PRO. Try it for free.

    SISI has a 52-week high of $4.90 and a 52-week low of $0.61.

    Get the next $SISI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SISI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $SISI
    SEC Filings

    View All

    Shineco Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events

    8-K - SHINECO, INC. (0001300734) (Filer)

    10/8/25 3:30:52 PM ET
    $SISI
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form NT 10-K filed by Shineco Inc.

    NT 10-K - SHINECO, INC. (0001300734) (Filer)

    9/29/25 6:15:10 AM ET
    $SISI
    Medicinal Chemicals and Botanical Products
    Health Care

    Shineco Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events

    8-K - SHINECO, INC. (0001300734) (Filer)

    7/30/25 7:35:46 PM ET
    $SISI
    Medicinal Chemicals and Botanical Products
    Health Care

    $SISI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Huang Shanchun claimed ownership of 5,041,667 shares (SEC Form 3)

    3 - SHINECO, INC. (0001300734) (Issuer)

    4/24/25 4:05:15 PM ET
    $SISI
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 3 filed by new insider Yan Chi Keung

    3 - SHINECO, INC. (0001300734) (Issuer)

    12/7/23 4:10:17 PM ET
    $SISI
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 3 filed by new insider Wang Xiaohui

    3 - SHINECO, INC. (0001300734) (Issuer)

    12/7/23 4:10:16 PM ET
    $SISI
    Medicinal Chemicals and Botanical Products
    Health Care

    $SISI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Shineco (SISI) Ignites Growth: $8.7M Tech Deal & Major Singapore Alliance Unleash Dual Engines

    BEIJING, Sept. 12, 2025 /PRNewswire/ -- Shineco Inc. (NASDAQ:SISI) ("Shineco" or the "Company"), a developer and commercializer of induced pluripotent stem cell (iPSC) technology platforms, today announced two major strategic advances. Its subsidiary, Xi'an Dong'ao Health Management Co., Ltd. ("Dong'ao Health"), has signed a technology services contract valued at US$8.7 million with Xinke Future Biotechnology (Bazhou) Co., Ltd. for the research and development of "microalgae-derived extracellular vesicles" technology. Separately, a delegation from Singapore's leading biotechnology company, BICC, completed a productive site visit to Dong'ao Health on September 10. The parties reached a broad

    9/12/25 9:30:00 AM ET
    $SISI
    Medicinal Chemicals and Botanical Products
    Health Care

    Shineco Achieves Mass Production of High-Purity Physical Phospholipids, Breaking Foreign Monopoly and Unlocking Innovation Across Industries

    BEIJING, Sept. 10, 2025 /PRNewswire/ -- Shineco Inc. (NASDAQ:SISI) ("Shineco" or the "Company"), a leading developer of induced pluripotent stem cell (iPSC) technology platforms, today announced that its subsidiary, Fuzhou Meidashan Biotechnology Co., Ltd., has successfully achieved large-scale production of high-purity, highly active free-form soybean phospholipids. This breakthrough was made possible through its proprietary APCC-UF pure physical extraction technology, overcoming a persistent global technical challenge in the field. Testing by multiple authoritative institutions confirms that the product's key metrics meet internationally leading standards, providing robust technical suppor

    9/10/25 9:30:00 AM ET
    $SISI
    Medicinal Chemicals and Botanical Products
    Health Care

    Shineco (NASDAQ: SISI) & BICC: From "Tech On-Chain" to "Global Redeemability"--RWA Ecosystem Takes Off for Long-Term Growth

    BEIJING, Aug. 27, 2025 /PRNewswire/ -- Shineco Inc. ((", Shineco", or the ", Company", , NASDAQ:SISI), a manufacturer of induced pluripotent stem cell (iPSC) technology platforms, has entered into a strategic cooperation agreement with Singapore-based BICC Pte Ltd to jointly promote the implementation and redemption of "on-chain cell assets" across multiple institutions and scenarios. This collaboration marks a new phase of "cross-enterprise redeemability" for cell assets on the blockchain, advancing the RWA ecosystem from "technical on-chain integration" to "real-world application. This partnership builds on Shineco's prior initiatives: establishing a Cell Digital Division,signing an agree

    8/27/25 6:30:00 AM ET
    $SISI
    Medicinal Chemicals and Botanical Products
    Health Care

    $SISI
    Leadership Updates

    Live Leadership Updates

    View All

    Shineco Establishes Biological Cell Digital Division to Integrate Biological Cell Assets and Blockchain Technology

    BEIJING, Aug. 13, 2025 /PRNewswire/ -- Shineco Inc. ((", Shineco", or the ", Company", , NASDAQ:SISI), a manufacturer of induced pluripotent stem cell (iPSC) technology platforms, today announced the establishment of a Biological Cell Digital Business Division (the "Division"), and the appointment of Mr. Lin Hongguang as General Manager, to advance the integration of its biological cell assets and blockchain technology. Through a new architecture of blockchain-based cell assets, Shineco aims to build a vertical ecosystem within the biological cell sector, accelerate the global distribution of biological cell products and boost global sales. The Division is expected to use blockchain technol

    8/13/25 6:30:00 AM ET
    $SISI
    Medicinal Chemicals and Botanical Products
    Health Care

    Future FinTech Announces the Appointment of Hu Li as the New CEO

    NEW YORK, Aug. 9, 2024 /PRNewswire/ -- Future Fintech Group Inc. (NASDAQ: FTFT), (hereinafter referred to as "Future FinTech", "FTFT" or the "Company"), a comprehensive financial and digital technology service provider, today announced that its Board of Directors (the "Board") approved the appointment of Mr. Hu Li as Chief Executive Officer ("CEO"), President and a member of the Board of the Company, effective August 5, 2024. Mr. Li will be fully responsible for the operation and management of the Company, helping it to expand internationally, manage its investment and financi

    8/9/24 9:00:00 AM ET
    $FTFT
    $SISI
    Real Estate
    Medicinal Chemicals and Botanical Products
    Health Care

    Shineco Announces the Appointment of Two New Executive Officers

    BEIJING, Nov. 17, 2023 (GLOBE NEWSWIRE) -- Shineco, Inc. (("Shineco" or the "Company", NASDAQ:SISI), a provider of technologically advanced healthcare products and services, announced today that its Board of Directors has appointed Ms. Xiaohui Wang and Mr. Chi Keung Yan as executive officers of the Company in key leadership roles. Effective November 13, 2023, Shineco's Board of Directors appointed Ms. Xiaohui Wang as Executive President of the Company. From March 2000 to November 2013, Ms. Wang was the founder and Chairperson of Chongqing Wintus (New Star) Enterprises Group, where she was responsible for its corporate planning, supervision of the group's business in the Chongqing region,

    11/17/23 9:00:00 AM ET
    $SISI
    Medicinal Chemicals and Botanical Products
    Health Care

    $SISI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Shineco Inc.

    SC 13G/A - SHINECO, INC. (0001300734) (Subject)

    10/25/24 2:45:17 PM ET
    $SISI
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13D filed by Shineco Inc.

    SC 13D - SHINECO, INC. (0001300734) (Subject)

    7/12/24 5:28:03 PM ET
    $SISI
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G filed by Shineco Inc.

    SC 13G - SHINECO, INC. (0001300734) (Subject)

    8/29/23 1:26:38 PM ET
    $SISI
    Medicinal Chemicals and Botanical Products
    Health Care